We could not find any results for:
Make sure your spelling is correct or try broadening your search.
DOLLAR GENERAL CORP COM $992,795,576 17,584,052 1,114,471 AGL RESOURCES INC COM $426,410,182 9,263,745 1,103,235 PIER 1 IMPORTS INC COM $108,256,866 5,545,946 1,101,639 SCHLUMBERGER NV COM...
DJ CFA SOURCE: SEC 13F-HR FILER: The Vanguard Group, Inc. QUARTER ENDED: 09/30/2013 SEC RECEIVED: 11/07/2013 Up to 200 of the largest sales of The Vanguard Group, Inc. are listed below, ordered...
SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) reported today that its Cardium Biologics division provided an update on plans for the continuing commercial...
SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to launch a new premium advanced skin care product line to promote foot health and comfort...
SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) reported that it received notification from the staff of the company's current listing exchange indicating that...
SAN DIEGO, Dec. 16 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported on recent clinical findings published in the December issue of Diabetes Care showing an increase...
SAN DIEGO, Dec. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced a presentation titled, "Phase 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic...
SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced today that its wholly-owned subsidiary, Tissue Repair Company, submitted a 510(k) premarket...
SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported its financial results for its third quarter ended September 30, 2009, and on recent developments...
SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | -0.002 | -10 | 0.02 | 0.021 | 0.017 | 836929 | 0.01934492 | DE |
12 | -0.019 | -51.3513513514 | 0.037 | 0.0385 | 0.017 | 1031758 | 0.02490767 | DE |
26 | -0.024 | -57.1428571429 | 0.042 | 0.044 | 0.017 | 698485 | 0.03008606 | DE |
52 | -0.05 | -73.5294117647 | 0.068 | 0.087 | 0.017 | 920810 | 0.04662998 | DE |
156 | -0.068 | -79.0697674419 | 0.086 | 0.22 | 0.017 | 1186732 | 0.11338245 | DE |
260 | -0.023 | -56.0975609756 | 0.041 | 0.22 | 0.017 | 1040356 | 0.10459031 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions